Clynav

Authorised

This medicine is authorised for use in the European Union

salmon pancreas disease vaccine (recombinant DNA plasmid)

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Clynav : EPAR - Medicine overview

Reference Number: EMA/278771/2016

Product information

Clynav : EPAR - Product Information

Clynav : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Clynav
• Active substance:
  pUK-SPDV-poly2#1 DNA plasmid coding for salmon pancreas disease virus proteins
• International non-proprietary name (INN) or common name:
  salmon pancreas disease vaccine (recombinant DNA plasmid)

Pharmacotherapeutic group

Immunologicals for Atlantic salmon

Authorisation details

• EMA product number:
  EMEA/V/C/002390

Assessment history

Changes since initial authorisation of medicine

Clynav : EPAR - Procedural steps taken and scientific information after authorisation

Clynav-V-C-2390-II-0010 : EPAR - Assessment report - Variation

Adopted Reference Number: EMA/101438/2020

CVMP post-authorisation summary of positive opinion for Clynav

Adopted Reference Number: EMA/CVMP/624348/2019

Initial marketing authorisation documents

Clynav : EPAR - Public assessment report

Adopted Reference Number: EMA/293169/2016

CVMP summary of positive opinion for Clynav

Adopted Reference Number: EMA/CVMP/223807/2016